<DOC>
	<DOCNO>NCT00899015</DOCNO>
	<brief_summary>RATIONALE : Studying bone marrow blood sample patient leukemia lymphoma treat arsenic trioxide may help doctor learn cancer . PURPOSE : This research study assess arsenic trioxide young patient recurrent refractory leukemia lymphoma treat clinical trial NCI-00-C-0070J .</brief_summary>
	<brief_title>Assessing Arsenic Trioxide Young Patients With Leukemia Lymphoma Who Were Treated Clinical Trial NCI-00-C-0070J</brief_title>
	<detailed_description>OBJECTIVES : - To assess pharmacokinetic pharmacodynamic profile arsenic trioxide pediatric patient treat protocol NCI-00-C-0070J . OUTLINE : Bone marrow peripheral blood mononuclear cell collect treatment NCI-00-C-0070J assess pharmacodynamics study . Plasma cell collect treatment assessed pharmacokinetics study . Total arsenic ( As ) , inorganic As form ( AsIII AsV ) , methylated metabolite As assess .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Arsenic trioxide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm leukemia lymphoma refractory standard curative treatment regimens No meningeal leukemia lymphoma No HIVrelated lymphoma No lymphoproliferative disease Received treatment protocol NCI00C0070J Bone marrow peripheral blood serum sample collect treatment NCI00C0070J available PATIENT CHARACTERISTICS : See NCI00C0070J PRIOR CONCURRENT THERAPY : See NCI00C0070J</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>childhood acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
	<keyword>atypical chronic myeloid leukemia , BCR-ABL1 negative</keyword>
</DOC>